Neoadjuvant chemotherapy (NACT) is the standard treatment for locally advanced, high-risk
breast cancer. Pathological complete response (pCR) improves survival. Peripheral blood …

The neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), systemic
immune severity index (SII), and prognostic nutritional index (PNI) are associated with the …

Purpose: Several biomarkers have been reported to correlate with neoadjuvant
chemotherapy response. Our aim was to establish the correlation between neutrophils-to …

Purpose Among patients with breast cancer, pathological complete response (pCR) to
neoadjuvant chemotherapy (NAC) is an important prognostic predictor of survival. This study …

Background The persistence of inflammatory stimulus has a tight relationship with the
development of age-related diseases, ultimately resulting in a gradual escalation in the …

Purpose The role of the host immunologic environment is crucial in cancer progression.
Recent studies revealed that neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte …

Objective Response to neoadjuvant chemotherapy (NAC) is predictive for survival times in
some patients with breast cancer (BC). The aim of this study is to explore the predictive …

Objective To investigate the role of platelet-to-lymphocyte ratio (PLR) in complete
pathological response (pCR) of breast cancer (BC) patients after neoadjuvant chemotherapy …

Background The methods used to predict the pathologic complete response (pCR) after
neoadjuvant chemotherapy (NAC) have some limitations. In this study, we aimed to develop …

Background Inflammation plays an important role in tumor proliferation, metastasis, and
resistance to chemotherapy. The systemic inflammation response index (SIRI), has been …